B2B
Hubro Therapeutics
Hubro Therapeutics develops precision medicines targeting RNA splicing mechanisms to treat neurological and rare diseases.
aliveseed
seed
Stage
2019
Founded
1
Funding Rounds
About
Hubro Therapeutics develops precision medicines targeting RNA splicing mechanisms to treat neurological and rare diseases.
Explore Hubro Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.